John Garratt

John Garratt

UNVERIFIED PROFILE

Are you John Garratt?   Register this Author

Register author
John Garratt

John Garratt

Publications by authors named "John Garratt"

Are you John Garratt?   Register this Author

15Publications

398Reads

42Profile Views

Diagnostic Accuracy in Fit-for-Purpose PD-L1 Testing.

Appl Immunohistochem Mol Morphol 2019 04;27(4):251-257

Canadian Immunohistochemistry Quality Control.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00129039-900000000-9873
Publisher Site
http://dx.doi.org/10.1097/PAI.0000000000000734DOI Listing
April 2019

Developing ALK Immunohistochemistry and In Situ Hybridization Proficiency Testing for Non-Small Cell Lung Cancer in Canada: Canadian Immunohistochemistry Quality Control Challenges and Successes.

Appl Immunohistochem Mol Morphol 2015 Nov-Dec;23(10):677-81

*Laboratory Medicine Program, University Health Network, University of Toronto, Toronto ‡Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON †Canadian Immunohistochemistry Quality Control §Department of Pathology, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAI.0000000000000267DOI Listing
August 2016

Standardization of positive controls in diagnostic immunohistochemistry: recommendations from the International Ad Hoc Expert Committee.

Appl Immunohistochem Mol Morphol 2015 Jan;23(1):1-18

*Department of Laboratory Hematology, Toronto General Hospital, University Health Network, University of Toronto, Toronto, ON **Vancouver Costal Health ††Vancouver General Hospital/University of British Columbia, Vancouver, BC ##Department of Pathology, University of Calgary, Calgary, AB, Canada †Canadian Immunohistochemistry Quality Control (CIQC), Vancouver, BC, Canada ‡Institute of Pathology, Aalborg University Hospital, Denmark §Nordic Immunohistochemistry Quality Control (NordiQC), Aalborg, Denmark ∥Griffith University School of Medicine, Gold Coast Campus ¶Australian Institute for Bioengineering and Nano-Technology, University of Queensland, Qld, Australia #Convenor Immunohistochemistry, Anatomical Pathology Program, RCPA QAP Pty Ltd., Sydney, Australia ‡‡Beth Israel Deaconess Medical Center §§Brigham and Women's Hospital, Harvard medical School, Boston, MA ∥∥UK National External Quality Assessment Scheme (UK NEQAS), University College London, London, UK ¶¶University of Washington, Seattle, WA ***Department of Pathology, Beijing Friendship Hospital, Capital Medical University, Beijing, China †††Chinese Committee for Pathology-Immunohistochemistry Quality Control (CCP-IHCQC) ‡‡‡Keck School of Medicine, University of Southern California, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/appliedimmunohist/2015/01000/St
Web Search
http://dx.doi.org/10.1097/PAI.0000000000000163DOI Listing
January 2015

HER2/neu testing in gastric cancer by immunohistochemistry: assessment of interlaboratory variation.

Arch Pathol Lab Med 2014 Nov;138(11):1495-502

From the Division of Anatomic Pathology, Department of Pathology and Laboratory Medicine, Vancouver General Hospital and the University of British Columbia, Vancouver, Canada (Drs Sheffield, Gilks, and Schaeffer and Mr Garratt); the Canadian Immunohistochemistry Quality Control Program, Vancouver (Mr Garratt and Drs Torlakovic and Gilks); the Department of Pathology and Laboratory Medicine, British Columbia Cancer Agency and the University of British Columbia, Vancouver (Dr Li-Chang and Mr Kalloger); and the Department of Laboratory Hematology, University Health Network, University of Toronto, Toronto, Ontario, Canada (Dr Torlakovic).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2013-0604-OADOI Listing
November 2014

Standardization of negative controls in diagnostic immunohistochemistry: recommendations from the international ad hoc expert panel.

Appl Immunohistochem Mol Morphol 2014 Apr;22(4):241-52

*Laboratory Medicine Program, University Health Network/University of Toronto, Toronto, ON #Department of Pathology, Lions Gate Hospital **Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada †Canadian Immunohistochemistry Quality Control ‡CAP-ACP National Standards Committee for High Complexity Testing/Immunohistochemistry §Griffith University School of Medicine, Gold Coast ¶Australian Institute for Bioengineering and Nanotechnology, University of Queensland, Qld, Australia ∥Convenor Immunohistochemistry, Anatomical Pathology Program, RCPA QAP Pty Ltd. ††University College London, UK NEQAS ICC&ISH, London, UK ‡‡ProPath, Dallas, TX §§Institute of Pathology, Aalborg University Hospital, Aalborg, Denmark ∥∥Nordic Immunohistochemical Quality Control (NordiQC) ¶¶Department of Pathology, University of Washington, Seattle, WA ##Department of Pathology, Keck School of medicine, University of Southern California, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/PAI.0000000000000069DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206554PMC
April 2014

Utility of a CEA, CD15, calretinin, and CK5/6 panel for distinguishing between mesotheliomas and pulmonary adenocarcinomas in clinical practice.

Am J Surg Pathol 2012 Oct;36(10):1503-8

Department of Pathology, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/PAS.0b013e31825d5371DOI Listing
October 2012

Improved breast cancer biomarker detection through a simple, high frequency, low cost external proficiency testing program.

Pathology 2010 Dec;42(7):637-42

Department of Pathology, Vancouver General Hospital and University of British Columbia, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/00313025.2010.520306DOI Listing
December 2010